Change search
ReferencesLink to record
Permanent link

Direct link
Vagus nerve stimulation for depression: Efficacy and safety in a European study.
Show others and affiliations
2008 (English)In: Psychological Medicine, ISSN 0033-2917, E-ISSN 1469-8978, Vol. 38, no 5, 651-661 p.Article in journal (Refereed) Published
Abstract [en]

Background: Vagus nerve stimulation (VNS) therapy is associated with a decrease in seizure frequency in partial-onset seizure patients. Initial trials suggest that it may be an effective treatment, with few side-effects, for intractable depression. Method: An open, uncontrolled European multi-centre study (D03) of VNS therapy was conducted, in addition to stable pharmacotherapy, in 74 patients with treatment-resistant depression (TRD). Treatment remained unchanged for the first 3 months; in the subsequent 9 months, medications and VNS dosing parameters were altered as indicated clinically. Results: The baseline 28-item Hamilton Depression Rating Scale (HAMD-28) score averaged 34. After 3 months of VNS, response rates (≥50% reduction in baseline scores) reached 37% and remission rates (HAMD-28 score <10) 17%. Response rates increased to 53% after 1 year of VNS, and remission rates reached 33%. Response was defined as sustained if no relapse occurred during the first year of VNS after response onset; 44% of patients met these criteria. Median time to response was 9 months. Most frequent side-effects were voice alteration (63% at 3 months of stimulation) and coughing (23%). Conclusions: VNS therapy was effective in reducing severity of depression; efficacy increased over time. Efficacy ratings were in the same range as those previously reported from a USA study using a similar protocol; at 12 months, reduction of symptom severity was significantly higher in the European sample. This might be explained by a small but significant difference in the baseline HAMD-28 score and the lower number of treatments in the current episode in the European study.

Place, publisher, year, edition, pages
2008. Vol. 38, no 5, 651-661 p.
Keyword [en]
vagus nerve stimulation therapy, treatment-resistant depression, pharmacotherapy, efficacy, safety
URN: urn:nbn:se:umu:diva-41002DOI: 10.1017/S0033291707001924OAI: diva2:404146
Available from: 2011-03-16 Created: 2011-03-16

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Adolfsson, Rolf
By organisation
In the same journal
Psychological Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 32 hits
ReferencesLink to record
Permanent link

Direct link